MBX Biosciences, Inc. (MBX)

MBX Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	39.78	49.35	30.52	24.21
Short-Term Investments	185.13	212.8	50.15	18.25
Cash & Short-Term Investments	224.91	262.15	80.68	42.46
Cash Growth	306.98%	224.94%	90.00%	-
Other Receivables	0.84	0.68	0.21	0.14
Receivables	0.84	0.68	0.21	0.14
Prepaid Expenses	2.97	3.65	2.45	1.52
Other Current Assets	0.47	0.8	0.13	0.08
Total Current Assets	229.19	267.29	83.47	44.21
Property, Plant & Equipment	2.28	1.2	0.67	0.84
Other Long-Term Assets	0.05	0.05	0.05	0.04
Total Assets	231.52	268.54	84.18	45.1
Accounts Payable	5.76	5.34	1.39	0.98
Accrued Expenses	5.85	5.55	2.38	2.32
Current Portion of Leases	0.14	0.17	0.15	0.14
Total Current Liabilities	11.76	11.05	3.93	3.43
Long-Term Leases	0.51	-	0.17	0.32
Other Long-Term Liabilities	0.02	0.04	0.19	0.07
Total Liabilities	12.28	11.09	4.29	3.82
Common Stock	0.01	0.01	0	0
Additional Paid-In Capital	400.02	394.89	3.05	0.41
Retained Earnings	-180.8	-137.51	-75.58	-43.02
Comprehensive Income & Other	0.01	0.06	0.06	0
Total Common Equity	219.24	257.44	-72.47	-42.61
Shareholders' Equity	219.24	257.44	79.89	41.27
Total Liabilities & Equity	231.52	268.54	84.18	45.1
Total Debt	0.65	0.17	0.32	0.46
Net Cash (Debt)	224.26	261.98	80.35	42
Net Cash Growth	307.64%	226.04%	91.31%	-
Net Cash Per Share	8.39	24.62	78.87	62.97
Filing Date Shares Outstanding	33.59	33.42	1.26	0.67
Total Common Shares Outstanding	33.59	33.42	1.26	0.67
Working Capital	217.43	256.24	79.54	40.78
Book Value Per Share	6.53	7.70	-57.65	-63.87
Tangible Book Value	219.24	257.44	-72.47	-42.61
Tangible Book Value Per Share	6.53	7.70	-57.65	-63.87
Machinery	1.14	1.11	0.24	0.23
Construction In Progress	0.76	-	0	-
Leasehold Improvements	0.39	0.39	0.37	0.35

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q